Titan Pharmaceuticals
TTNP
#10689
Rank
โ‚น0.58 B
Marketcap
โ‚น437.30
Share price
-3.76%
Change (1 day)
27.22%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น416.43. In 2023 the company made an earnings per share (EPS) of -โ‚น702.90 an increase over its 2022 EPS that were of -โ‚น1,441.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น702.90-51.22%
2022-โ‚น1,441-15.61%
2021-โ‚น1,707-81.37%
2020-โ‚น9,163-77.52%
2019-โ‚น40,770-56.32%
2018-โ‚น93,342-59.51%
2017-โ‚น2,30,555-371.81%
2016โ‚น84,821-144.35%
2015-โ‚น1,91,237300%
2014-โ‚น47,809-121.54%
2013โ‚น2,21,972-151.38%
2012-โ‚น4,31,991-11.54%
2011-โ‚น4,88,338188.89%
2010-โ‚น1,69,040-10%
2009-โ‚น1,87,822
2007-โ‚น7,70,071-2.38%
2006-โ‚น7,88,854-39.13%
2005-โ‚น12,95,974-16.87%
2004-โ‚น15,58,925-22.43%
2003-โ‚น20,09,6994.9%
2002-โ‚น19,15,78861.9%
2001-โ‚น11,83,281-13.7%
2000-โ‚น13,71,10365.01%
1999-โ‚น8,30,935-35.87%
1998-โ‚น12,95,753-1824.71%
1997โ‚น75,129-102.4%
1996-โ‚น31,36,633

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น828.72-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น665.91-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น134.70-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.27-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.71-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น369.00-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA